349 related articles for article (PubMed ID: 8773434)
21. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
Kaiser B; Fareed J
Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
[TBL] [Abstract][Full Text] [Related]
22. Sustained inhibition of whole-blood clot procoagulant activity by inhibition of thrombus-associated factor Xa.
McKenzie CR; Abendschein DR; Eisenberg PR
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1285-91. PubMed ID: 8857926
[TBL] [Abstract][Full Text] [Related]
23. Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients.
Zafar MU; Farkouh ME; Osende J; Shimbo D; Palencia S; Crook J; Leadley R; Fuster V; Chesebro JH
Thromb Haemost; 2007 Mar; 97(3):487-92. PubMed ID: 17334518
[TBL] [Abstract][Full Text] [Related]
24. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
[TBL] [Abstract][Full Text] [Related]
25. Expression and assembly of procoagulant complexes by human pleural mesothelial cells.
Kumar A; Koenig KB; Johnson AR; Idell S
Thromb Haemost; 1994 May; 71(5):587-92. PubMed ID: 8091385
[TBL] [Abstract][Full Text] [Related]
26. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Hedner U; Erhardtsen E
Ann Med; 2000 Dec; 32 Suppl 1():68-72. PubMed ID: 11209985
[TBL] [Abstract][Full Text] [Related]
27. Activation of the factor VII-tissue factor pathway.
Bauer KA
Thromb Haemost; 1997 Jul; 78(1):108-11. PubMed ID: 9198137
[TBL] [Abstract][Full Text] [Related]
28. Thrombogenicity of small-diameter prosthetic grafts: relative contributions of graft-associated thrombin and factor Xa.
Toursarkissian B; Eisenberg PR; Abendschein DR; Rubin BG
J Vasc Surg; 1997 Apr; 25(4):730-5. PubMed ID: 9129631
[TBL] [Abstract][Full Text] [Related]
29. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.
Wielders SJ; Béguin S; Hemker HC; Lindhout T
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1138-42. PubMed ID: 15072993
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor and its inhibition at the human microvascular anastomosis.
Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC
J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of thrombin attenuates stenosis after arterial injury in minipigs.
Abendschein DR; Recchia D; Meng YY; Oltrona L; Wickline SA; Eisenberg PR
J Am Coll Cardiol; 1996 Dec; 28(7):1849-55. PubMed ID: 8962575
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
Sultan Y; Loyer F
J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
[TBL] [Abstract][Full Text] [Related]
33. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro.
Biedermann B; Rosenmund A; Muller M; Kohler HP; Haeberli A; Straub PW
J Lab Clin Med; 1994 Sep; 124(3):339-47. PubMed ID: 8083577
[TBL] [Abstract][Full Text] [Related]
34. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
35. rFVIIai in Acute Coronary Syndromes.
Sorensen BB; Hedner U; Erhardtsen E
Semin Vasc Med; 2003 May; 3(2):199-204. PubMed ID: 15199483
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.
Nicolini FA; Lee P; Malycky JL; Lefkovits J; Kottke-Marchant K; Plow EF; Topol EJ
Blood Coagul Fibrinolysis; 1996 Jan; 7(1):39-48. PubMed ID: 8845461
[TBL] [Abstract][Full Text] [Related]
37. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
White BN; Cox AC; Taylor FB
J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
[TBL] [Abstract][Full Text] [Related]
38. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
von dem Borne PA; Cox LM; Bouma BN
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
[TBL] [Abstract][Full Text] [Related]
39. Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
Hong TT; Van Gorp CL; Cardin AD; Lucchesi BR
Thromb Res; 2006; 117(3):333-42. PubMed ID: 15893368
[TBL] [Abstract][Full Text] [Related]
40. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells.
Bretschneider E; Braun M; Fischer A; Wittpoth M; Glusa E; Schrör K
Thromb Haemost; 2000 Sep; 84(3):499-505. PubMed ID: 11019978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
